In Group 1, glycoprotein acetyls (GlycA) was the most significantly increased metabolite in SLE patients compared with HCs, whilst a greater number of metabolites were decreased in concentration, including citrate, glutamine, albumin, acetoacetate, ApoA1 and multiple HDL particle measures. This evidence concerns the gene APOA1 and systemic lupus erythematosus.